- Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617
-
Mahmoudi E, Pirayesh E, Deevband M, Amoui M, Ghorbani Rad M, Ghorbani M
- KMID: 2521461
- Nucl Med Mol Imaging.
- 2021 Oct;55(5):237-244.
- doi: 10.1007/s13139-021-00713-7
Purpose 177Lu-DKFZ-PSMA-617 is a promising treatment for patients with metastatic prostate cancer. Specific dosimetry for each patient is an important factor in planning the patient’s treatment process. This study aimed... -
- CITED
-
- Close
- SHARE
-
- Close
